GZMO licensing deal with NeuralStem

Genzyme Molecular Oncology (GZMO) granted CNS drug discovery company NeuralStem (College Park, Md.) a license to SAGE genomics technology. NeuralStem plans to evaluate gene expression in its human CNS...